Related Experiment Video
Updated: Apr 3, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
3 × 3 model for drug use normalisation: Insights from a scoping review
Daniëlle T P Ketelaars1, Alexandra J Karl1, Maartje Luijten2
1Novadic-Kentron, Network for Addiction Treatment Services, PO Box 243, 5260 AE Vught, the Netherlands.
Background:
Drug use normalisation has been conceptualised through diverse terminologies and conceptual approaches. While early studies provided only a partial perspective, more recent research has adopted increasingly comprehensive and nuanced approaches. Despite these conceptual advancements, a unified and contemporary definition with clearly operationalised measures remains lacking.
Objective:
This scoping review investigates how drug use normalisation is defined and measured in the literature, to inform the development of a model assessing drug use normalisation.
Method:
A systematic search was conducted across MEDLINE, PsycINFO, Embase, Web of Science, and grey literature sources for studies that focused on the normalisation of recreational illicit drugs, published from 1994 to 2024. Screening and selection followed a predefined data extraction protocol, capturing definitions and criteria. Data were analysed thematically.
Results:
From 40 studies, 32 codes were identified and grouped into 10 themes across five conceptual categories: (1) Multi-Level Process, (2) Differentiated Normalisation, (3) Access and Policy, (4) Drug Use, and (5) Legitimacy. These categories constitute the foundation of a proposed 3 × 3 model, which defines drug use normalisation as a dynamic, multidimensional, and context-dependent process whereby recreational illicit drug use becomes increasingly accessible, prevalent, and perceived as legitimate across macro (societal), meso (contextual), and micro (individual) levels.
Conclusion:
The proposed model provides a comprehensive operationalisation that captures all dimensions and levels of the concept drug use normalisation. The model has the potential to improve conceptual clarity, support more consistent measurement, and inform future research, monitoring, prevention, and policymaking.
Related Concept Videos
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Three-Compartment Open Model
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Mechanistic Models: Compartment Models in Individual and Population Analysis
Pharmacodynamic Models: Emax Drug–Concentration Effect Model
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

